Orforglipron Cost and Price: What Could Affect the Cost?

• GPhC registered UK pharmacy and weight loss clinic, registration number 9012878
• Transparent pricing with no hidden fees and clinical support included
• Online consultation with UK registered prescribers for weight management
• Independent prescriber review and clinical assessment before any supply

The price of orforglipron in the UK is not one number. It is a private prescription medicine, authorised by the MHRA on 10 August 2026 and supplied through registered pharmacies. The private cost of orforglipron in the UK may vary according to the dose strength, quantity supplied, whether clinical consultations and follow-up are included, and delivery charges. Different pharmacies may structure these costs differently.

This guide from the EveryDayMeds pharmacy team explains each of the factors that shape the cost, shows how to compare pharmacies on a like for like basis over a full year rather than a first month, and sets out the costs that are not savings, because a low price for an unlicensed or counterfeit product costs more than any genuine supply. It does not quote figures. Prices change, and the only price worth relying on is the one on the pharmacy's live page at the time you order.

What decides the price of orforglipron?

Six factors can affect what you pay for orforglipron privately

Key things to know

• Orforglipron is a prescription only medicine supplied privately in the UK after an assessment by a registered prescriber. For weight management, orforglipron is authorised for adults with a BMI of 30 or above, or a BMI of 27 to 30 with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity.
• The dose is increased in steps set by the prescriber, so the strength you are on changes over the first months, and the price may change with it.
• A first-month price may not represent the ongoing monthly cost, particularly if the price changes with dose or if the first consultation is included.
• An unusually low price should prompt you to check whether the seller is a legitimate UK pharmacy and whether the product is authorised and supplied following a valid prescription.
• The UK indication specifies use alongside a reduced-calorie diet and increased physical activity.
• Treatment suitability depends on an individual clinical assessment, and price is never a reason for a prescriber to supply a medicine to someone who does not meet the licensed criteria. Orforglipron is not recommended during pregnancy, and people who are pregnant, planning pregnancy or breastfeeding should discuss treatment with their prescriber.

Why is there no single UK price?

Because orforglipron is supplied privately, and private pharmacies set their own prices. The manufacturer's UK list price is the starting point, and each pharmacy adds what it charges for the prescriber's time, the pharmacist's checks, packaging, delivery and ongoing support. Pharmacies also differ in how they present those charges: some fold everything into a single monthly figure, some list the medicine and the service separately, and some price by strength. None of these approaches is wrong, but they make first glance comparisons misleading. Orforglipron is newly authorised in the UK, and private providers may set different prices for the medicine and associated clinical services. NHS availability and funding are separate questions from private pricing.

How does the dose affect the monthly cost?

The dose affects the monthly cost because orforglipron is started low and increased in steps, and pharmacies commonly price the strengths differently. A price quoted for the starting strength is not the price you will pay once the prescriber has moved you up, and the strength you settle on for the long term is decided by your response and tolerance, not by the price list.

What do the dose steps mean for a year's cost?

They mean that the first months and the later months may cost different amounts, and that a year's total is the sum of several strengths rather than one price multiplied by twelve. Dose steps are clinical decisions. A prescriber increases the dose according to the authorised dosing schedule and how well you tolerate treatment. Asking a pharmacy for its price at each strength, and for a typical progression, lets you estimate a realistic year. Asking for the starting price alone does not.

Can you save money by staying on a lower dose?

Not as a strategy, and not on request. The dose is set by the prescriber for clinical reasons. Some people do stay on a lower strength because it controls their appetite and is well tolerated, and their cost is lower as a result, but that is an outcome of the assessment rather than a choice made to reduce the bill. Dose selection should be based on clinical response and tolerability rather than cost alone. Do not change your dose without discussing it with your prescriber. Never double a missed dose, and do not take more than one tablet in a day after a missed dose.

What is included in the price, and what is extra?

What is included varies, and the difference between two pharmacies' prices is often the service rather than the medicine.

What should you ask a pharmacy before comparing prices?

1. Is the price for the medicine only, or does it include the consultation?
2. Which strength does the price refer to, and what do the other strengths cost?
3. Are dose review consultations included, and how are they carried out?
4. Is delivery included, and is the medicine sent in temperature appropriate packaging where that applies?
5. Can I pause or cancel, and is there a charge?
6. Is the pharmacy on the GPhC register, and is the prescriber registered with their regulator?
7. Is the product the UK licensed medicine, supplied with its patient information leaflet, and can you check the licensed product details in the electronic medicines compendium entry or other official electronic medicines information?

The answers turn a list of monthly figures into a comparison of the same thing. Official sources matter when comparing instructions, side effects, and formulation claims.

How do you compare the cost over a year?

You compare the cost over a year by adding up everything you would pay for twelve months of treatment at each pharmacy, using the same assumptions for each. The first month is a poor guide, because it usually covers the starting strength and may or may not include the consultation.

1. Write down the dose progression a prescriber would typically follow, from the starting strength to a holding strength. A pharmacy can tell you what is usual, though your own progression will be decided clinically.
2. Price each month at the strength you would be on, using each pharmacy's price for that strength.
3. Add the consultation charges: the initial assessment and each dose review, if charged.
4. Add delivery for every order.
5. Add any subscription, cancellation or administration fees.
6. Compare the totals, not the first months.

A pharmacy that looks costly in month one because it includes the consultation can be the lower cost option over a year. A pharmacy that looks inexpensive in month one because it prices the starting strength alone can cost more by month six.

What commonly goes wrong?

• Comparing a first month price with a full service price.
• Assuming the starting strength price is the monthly price.
• Ignoring delivery over twelve orders.
• Choosing by price and discovering there is no follow up when side effects arrive at a dose step.
• Buying several months up front before knowing whether the medicine is tolerated.
• Treating the very low price online as genuine.

Which costs are not savings?

Some low prices cost more than the medicine, because what is supplied is not the medicine at all.

• Unlicensed or imported products. Orforglipron is authorised in the UK as a specific licensed product.Products sold outside the authorised UK supply route may not be the UK-authorised product and may not have the same regulatory controls. Check the source carefully.
• Counterfeits. The MHRA has warned about counterfeit and unlicensed weight-loss medicines being sold online. The MHRA has warned repeatedly about fake GLP-1 products sold online, some containing nothing, some containing a different medicine, some containing harmful substances.
• Supply without a prescription. Orforglipron is prescription-only in the UK and should be supplied through an appropriate prescribing and pharmacy route.
• Sharing or splitting. Tablets are prescribed to one person at one strength. Do not share your prescribed tablets or alter your prescribed dose to reduce costs.
• Skipping the assessment to save the fee. The medical history questions exist because the GLP-1 class carries serious, if uncommon, risks, and a prescriber's check is part of what you pay for. That includes screening for how treatment may affect the digestive system, reviewing common side effects such as nausea, vomiting, and diarrhea.The clinical assessment helps the prescriber determine whether treatment is appropriate and identify potential risks, contraindications and interactions.

How do you check if a pharmacy is legitimate?

Every UK pharmacy, including online ones, must be on the GPhC register, which can be searched by name or registration number. UK medicines are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA), while pharmacies in Great Britain are regulated by the General Pharmaceutical Council (GPhC). A legitimate service asks the questions a prescriber needs before supplying, states the prescriber's registration, supplies the UK licensed product with its leaflet, and offers follow up. Any price from a seller that fails those tests is not a price for orforglipron.

How does the cost compare with other weight loss medicines?

Comparing the cost of orforglipron with other weight-management medicines requires more than looking at the price of one pack. Dose, treatment duration, consultations, delivery and the level of clinical support can all affect the total cost. Clinical trial results for different medicines also come from different study populations and designs, so their average weight-loss results should not be treated as a direct comparison. Orforglipron has not been compared head-to-head with injectable weight-management medicines in a trial designed to establish which produces greater weight loss.

What does the evidence say the medicine delivers?

In ATTAIN-1, 3,127 adults were followed for 72 weeks. At the highest dose, mean weight loss was 12.4% with orforglipron versus 0.9% with placebo using the efficacy estimand. Using the treatment-regimen estimand, the corresponding figures were 11.2% and 2.1%. Results varied between individuals. Lower doses produced smaller average losses. Results vary between individuals, including adults with obesity or overweight and at least one weight related health condition, and the trial assumed a reduced calorie diet and increased physical activity alongside the medicine, which is also what the UK licence requires.

How long will you be paying for?

Treatment may continue for as long as the prescriber considers it appropriate for long-term weight management. Some people regain weight after stopping weight-loss medicines, so ongoing weight-management strategies and regular clinical review are important.

What can reduce the cost without reducing safety?

• Choosing a pharmacy that includes consultations and follow up rather than charging for each.
• Ordering monthly until the medicine is tolerated, then considering longer supplies if the pharmacy prices them lower and you can pause them.
• Using the pharmacy's support for side effects rather than a separate appointment elsewhere.
• Following the recommended diet and physical-activity plan as part of your overall weight-management treatment.
• Never buying outside the regulated route to save money, for all the reasons above.

How can EveryDayMeds help?

Our pricing is transparent: the price shown for a medicine on our site is the standard price, with no hidden fees, and our confidential online consultation with UK registered prescribers, independent prescriber review and pharmacy support are part of the service. Ask us for the price at each strength and for a realistic year, and ask whether orforglipron is available through our clinic at the time of your consultation, because availability of a newly launched medicine can change and the prescriber will discuss alternative weight loss treatments if it is not. EveryDayMeds is a GPhC registered UK pharmacy and weight loss clinic, registration number 9012878, and every medicine we supply is genuine and UK sourced.

Medically supervised prescription weight loss treatment is available to adults living with obesity and, in some cases, adults who are overweight with a weight-related medical condition such as high blood pressure, subject to an individual clinical assessment. Treatment suitability, and whether any weight loss medication is appropriate, are decided by the prescriber and never by the price.

Medical Disclaimer

This article is for general information only and does not replace advice from a doctor, pharmacist or other qualified healthcare professional. It does not recommend any specific medicine or dose, and it does not quote prices, which change and should be checked on the pharmacy's live page at the time of ordering. Orforglipron is a prescription only medicine that should only be used under the supervision of an appropriately qualified prescriber, within its UK licence.Treatment may not be suitable for everyone and depends on an individual clinical assessment. Always read the patient information leaflet, discuss how your body responds to treatment with your prescriber, and seek urgent medical help for serious allergic reactions or symptoms of low blood sugar where relevant.